Jerry Bryant

751 total citations
24 papers, 589 citations indexed

About

Jerry Bryant is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jerry Bryant has authored 24 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jerry Bryant's work include Radiopharmaceutical Chemistry and Applications (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Medical Imaging and Pathology Studies (5 papers). Jerry Bryant is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Medical Imaging and Pathology Studies (5 papers). Jerry Bryant collaborates with scholars based in United States, Sweden and China. Jerry Bryant's co-authors include David J. Yang, Dongfang Yu, Ali Azhdarinia, Donald A. Podoloff, Chang‐Sok Oh, Naomi R. Schechter, E. Edmund Kim, Jonathan King, Payal Mehta and Eun‐Mi Kim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jerry Bryant

24 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerry Bryant United States 14 209 173 165 106 86 24 589
Christine Sikora United States 8 327 1.6× 76 0.4× 302 1.8× 201 1.9× 78 0.9× 9 669
Hailong Pei China 17 131 0.6× 128 0.7× 390 2.4× 149 1.4× 211 2.5× 49 734
Dexiao Yuan China 18 203 1.0× 85 0.5× 408 2.5× 165 1.6× 255 3.0× 26 753
Gabriele Alessandrini Italy 13 38 0.2× 142 0.8× 255 1.5× 142 1.3× 92 1.1× 36 613
Helen Chin-Sinex United States 13 76 0.4× 160 0.9× 342 2.1× 54 0.5× 153 1.8× 26 544
Kyungmi Yang South Korea 13 81 0.4× 117 0.7× 254 1.5× 90 0.8× 61 0.7× 48 563
Takao Iwaguchi Japan 12 70 0.3× 115 0.7× 383 2.3× 33 0.3× 122 1.4× 50 706
Tohru Takashi Japan 16 143 0.7× 184 1.1× 312 1.9× 76 0.7× 69 0.8× 35 1.0k
Chian‐Feng Chen Taiwan 18 48 0.2× 150 0.9× 533 3.2× 87 0.8× 240 2.8× 32 830
Shigekazu Nakatsugawa Japan 13 102 0.5× 81 0.5× 227 1.4× 70 0.7× 83 1.0× 28 439

Countries citing papers authored by Jerry Bryant

Since Specialization
Citations

This map shows the geographic impact of Jerry Bryant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry Bryant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry Bryant more than expected).

Fields of papers citing papers by Jerry Bryant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerry Bryant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry Bryant. The network helps show where Jerry Bryant may publish in the future.

Co-authorship network of co-authors of Jerry Bryant

This figure shows the co-authorship network connecting the top 25 collaborators of Jerry Bryant. A scholar is included among the top collaborators of Jerry Bryant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerry Bryant. Jerry Bryant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pham, Lan, et al.. (2018). Novel formulation of cannabinoid analogues used in cancer therapy.. Journal of Clinical Oncology. 36(15_suppl). e19536–e19536. 1 indexed citations
2.
3.
Pham, Lan V., et al.. (2018). Synergistic Effect of Cannabidiol with Conventional Chemotherapy Treatment. Blood. 132(Supplement 1). 5382–5382. 8 indexed citations
4.
Pham, Lan V., Jerry Bryant, Richard Mendez, et al.. (2016). Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma. Oncotarget. 7(49). 80599–80611. 25 indexed citations
5.
Yang, David J., Fanlin Kong, Takashi Oka, & Jerry Bryant. (2012). Molecular Imaging Kits for Hexosamine Biosynthetic Pathway in Oncology. Current Medicinal Chemistry. 19(20). 3310–3314. 6 indexed citations
6.
7.
Yang, David J., et al.. (2008). Challenges and Opportunities in Molecular Imaging. Current Medical Imaging Formerly Current Medical Imaging Reviews. 4(1). 46–50. 2 indexed citations
8.
Azhdarinia, Ali, David J. Yang, Dongfang Yu, et al.. (2005). Regional Radiochemotherapy Using In Situ Hydrogel. Pharmaceutical Research. 22(5). 776–783. 27 indexed citations
9.
Yang, David J., Chang‐Sok Oh, Ali Azhdarinia, et al.. (2005). 99mTc-EC-Guanine: Synthesis, Biodistribution, and Tumor Imaging in Animals. Pharmaceutical Research. 22(9). 1471–1479. 15 indexed citations
10.
Yang, David J., Masashi Yukihiro, Dongfang Yu, et al.. (2004). Assessment of Therapeutic Tumor Response Using 99mTc-Ethylenedicysteine-Glucosamine. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 443–456. 33 indexed citations
11.
Yang, David J., Masashi Yukihiro, Dongfang Yu, et al.. (2004). Assessment of Therapeutic Tumor Response Using <SUP>99m</SUP>Tc-Ethylenedicysteine-Glucosamine. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 443–456. 7 indexed citations
12.
Yang, David J., Jerry Bryant, Richard Mendez, et al.. (2004). Assessment of cyclooxygense-2 expression with 99mTc-labeled celebrex. Anti-Cancer Drugs. 15(3). 255–263. 25 indexed citations
13.
Yang, David J., Naomi R. Schechter, Ali Azhdarinia, et al.. (2003). Imaging with99mTc ECDG Targeted at the Multifunctional Glucose Transport System: Feasibility Study with Rodents. Radiology. 226(2). 465–473. 116 indexed citations
14.
Schechter, Naomi R., David J. Yang, Ali Azhdarinia, et al.. (2003). Assessment of epidermal growth factor receptor with 99mTc–ethylenedicysteine–C225 monoclonal antibody. Anti-Cancer Drugs. 14(1). 49–56. 33 indexed citations
15.
Yukihiro, Masashi, et al.. (2003). Assessment of tumor growth with 99mTc-EC-glucosamine. 299. 1 indexed citations
16.
Yang, David J., Naomi R. Schechter, Dongfang Yu, et al.. (2002). Assessment of Antiangiogenic Effect Using 99m Tc-EC-Endostatin. Cancer Biotherapy and Radiopharmaceuticals. 17(2). 233–246. 37 indexed citations
17.
18.
Mehta, Jawahar L., Jerry Bryant, & Paulette Mehta. (1995). Reduction of nitric oxide synthase activity in human neutrophils by oxidized low-density lipoproteins. Biochemical Pharmacology. 50(8). 1181–1185. 14 indexed citations
19.
Yang, Byoung‐Chul, Tom Saldeen, Jerry Bryant, Wilmer W. Nichols, & J. L. Mehta. (1993). Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. American Heart Journal. 126(6). 1287–1292. 43 indexed citations
20.
Bryant, Jerry, et al.. (1992). Co-purification of 130 KD nitric oxide synthase and A 22 KD link protein from human neutrophils. Biochemical and Biophysical Research Communications. 189(1). 558–564. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Sikora Breakdown of academic impact, for papers by Hailong Pei Breakdown of academic impact, for papers by Dexiao Yuan Breakdown of academic impact, for papers by Gabriele Alessandrini Breakdown of academic impact, for papers by Helen Chin-Sinex Breakdown of academic impact, for papers by Kyungmi Yang Breakdown of academic impact, for papers by Takao Iwaguchi Breakdown of academic impact, for papers by Tohru Takashi Breakdown of academic impact, for papers by Chian‐Feng Chen Breakdown of academic impact, for papers by Shigekazu Nakatsugawa
Rankless by CCL
2026